TRMT6 and breast cancer: Monshaugen et al. 78 demonstrated that depletion of TRMT6/TRMT61A sensitizes 5,637 BC cells to tunicamycin, a cellular stress inducer, indicating TRMT6/TRMT61A role in stress response and tolerance.